This message was sent to ##Email## To advertise in this publication please click here October 15, 2020 .ASSOCIATION NEWS Last Day to Save $99 on the ITNS Annual Meeting Join your transplant nursing community for the first ever virtual ITNS Annual Meeting, October 22-25, 2020. Your registration gives you access to all educational sessions and e-posters for one year! For a limited time save $99 USD. Use code SAVE99 and register by October 15 to save. Learn more. DAISY Foundation Now Accepting Applications for New Health Equity Grants The DAISY Foundation is eager to support the delivery of patient- and family-centered care by funding nursing research and EBP projects that address interventions to improve the health of people/families affected by social determinants of health. This funded work will contribute to the evidence base of interventions that improve the health outcomes of disadvantaged patients and families. Learn more. .INDUSTRY NEWS Vanderbilt University Medical Center has performed the world's first heart-lung transplant of a COVID-19 patient Penn Live Vanderbilt University Medical Center revealed in an Oct. 8 press release that a COVID-19 patient was the recipient of a heart-lung transplant at the hospital, located in Nashville, Tennessee, on Sept. 24, 2020 - marking “the world’s first dual heart-lung transplant of a COVID-19 patient.” READ MORE Clinical characteristics, hospitalization and mortality rates of COVID-19 among liver transplant patients in the United States Gastroenterology Liver transplant patients represent one of the largest immunosuppressed cohorts. However, outcomes of COVID-19 in this population remain poorly defined, although liver injury has been reported in patients with COVID-19. Researchers sought to examine characteristics of LT patients infected with COVID-19 and study the rates of hospitalization, mortality, thrombosis, or ICU requirement in LT with COVID-19 in the U.S. READ MORE  SPONSORED VIDEO Important Factors in Kidney Transplant Explore some of the many factors that can put a graft at risk, including CYP3A5*1 expression, declining adherence, and nephrotoxicity. In addition, review pharmacokinetic and clinical data that may be relevant to your practice and patients. See the Video WATCH VIDEO Clinical implications of SARS-CoV-2 cycle threshold values in solid organ transplant recipients DocWire News Detection of SARS-CoV-2 viral RNA by RT-PCR assays is the primary diagnostic test for COVID-19. Cycle threshold values generated by some of these assays provide inversely proportional proxy measurements of viral load. The clinical implications of CT values are incompletely characterized, particularly in solid organ transplant recipients. READ MORE Variation in racial disparities in liver transplant outcomes across transplant centers in the United States Urban Health Today Little is known about the role that transplant centers may play in perpetuating racial disparities after liver transplantation, which are unexplained by patient-level factors. Researchers examined variation in between- and within-center disparities among 34,114 Black and white liver transplant recipients in the United States from 2010 to 2017 using Scientific Registry of Transplant Recipient data. READ MORE  SPONSORED CONTENT Promoted by Natera National Kidney Foundation CME Course: Evaluation of Acute Allograft Rejection in Kidney Transplantation KDIGO Webinar: The Critical Role of Genetics in Kidney Disease NEW: The Renasight Genetic Panel Can Inform the Care Path for Patients Diagnosed with CKD Learn about Prospera for a Better Kidney Transplant Rejection Assessment Why Prospera is the Right Choice for Managing Transplant Recipients Remotely Engaging in kidney transplant process may lead to more 'aggressive' end-of-life care Healio A study of Medicare beneficiaries showed those who participated in the transplant process received more intensive end-of-life care than other patients with end-stage kidney disease. “Available evidence suggests that for patients with advanced kidney disease, hopes and expectations around kidney transplant strongly shape their prognostic expectations and may affect how they think about and plan for the future,” Catherine R. Butler, MD, of the University of Washington, and colleagues wrote. “Little is currently known about how engagement in the kidney transplant process — whether this be in the form of evaluation, waitlisting or receipt of a kidney transplant — might shape the care that patients receive as they approach the end of life.” READ MORE 5-year single cener early experience of heart transplantation from donation after circulatory determined death donors The Journal of Heart and Lung Transplantation In an effort to address the increasing demand for heart transplantation within the United Kingdom, researchers established a clinical program of heart transplantation from donation after circulatory determined death donors in 2015. Five years later, they report the clinical early outcomes and impact of the program. READ MORE Advertisement  FEATURED ARTICLE   Financial support for kidney transplant patients Veloxis Pharmaceuticals Immunosuppressive medications can be a financial burden for kidney transplant patients, potentially costing as much as $10,000 to $14,000 a year. These expenses can have a negative impact on patients’ lives and may play a role in medication nonadherence, which is associated with transplant failure. Learn more about support that is available with a free 30-day trial to allow your patients to start immediately at no cost. And, for patients who are eligible with commercial insurance coverage, a $0 co-pay card offers significant savings. Find out more LEARN MORE   Absolute lymphocyte count as marker of cytomegalovirus and allograft rejection: Is there a 'safe corridor' after kidney transplantation? Physician's Weekly The contrasting outcomes of lymphocyte manipulation after solid organ transplantation are allograft rejection and infections, commonly with cytomegalovirus. Peripheral blood absolute lymphocyte count may serve as a predictive marker for these outcomes. Using a retrospective review of clinical and laboratory dataset, researchers aimed to determine whether a range of ALC exists where CMV infection and rejection outcomes are minimal in a cohort of 381 kidney transplant recipients. READ MORE Pre-existing melanoma and hematological malignancies, prognosis and timing to solid organ transplantation American Journal of Transplantation Patients undergoing evaluation for solid organ transplantation frequently have a history of malignancy. Only patients with treated cancer are considered for SOT but the benefits of transplantation need to be balanced against the risk of tumor recurrence, taking into consideration the potential effects of immunosuppression. READ MORE   ITNS Insider Connect with ITNS Dennis Hall, Director of Publishing, MultiView, 469-420-2656 | Download media kit Anne Casey, Content Editor, MultiView, 469-420-2619 | Contribute news International Transplant Nurses Society 8735 W. Higgins Road, Suite 300 | Chicago, IL 60631 847-375-6340  |  Contact Us  |  www.itns.org Click here to unsubscribe.  Learn how to add us to your safe sender list so our emails get to your inbox. ADVERTISE SUBSCRIBE PAST ISSUES   7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063